On a different level: Telavancin versus vancomycin for hospital-acquired pneumonia

Clinical Infectious Diseases

Volumn 52, Issue 11, 2011, Pages 1390-

  Tarchini, Giorgio ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELAVANCIN; VANCOMYCIN;

BACTERIAL PNEUMONIA; DRUG BLOOD LEVEL; DRUG EFFICACY; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CROSS INFECTION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME; VANCOMYCIN;

EID: 79957492789     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir189     Document Type: Letter

References (5)

1. Rubinstein E, Lalani T, Corey GR, et al. Telavancin versus vancomycin for hospitalacquired pneumonia due to gram-positive pathogens. Clin Infect Dis 2011; 52:31-40.
2. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
3. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:285-92.
4. Jeffres MN, Isakow W, Doherty JA, Micek ST, KollefMH. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther 2007; 29:1107-15. (Pubitemid 47208584)
5. Chang F-Y, Peacock JE Jr., Musher DM, et al. Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 2003; 82:333-9. (Pubitemid 37229468)